Abstract
Background and objectives: Hip fracture is a major public health issue. Those fractures lead to high costs and a decrease in quality of life. A national French survey was conducted, with the objectives to firstly assess the current management of hip fracture and its prevention, both in the osteoporotic and cancer settings, and secondly to evaluate the opinions of physicians on the potential use of minimally invasive implantable devices to prevent hip fracture in alternative of surgery. Materials and methods: This national survey was conducted in France between April and July 2017. Questionnaires were sent to orthopedic surgeons, interventional radiologists, oncologists, and rheumatologists. Completed questionnaires were analyzed and compared according to two indications: orthopedics-traumatology and oncology. Factors associated with these responses were assessed using univariable analyses, based on chi-square tests or an exact Fisher test, as appropriate. Results: A total of 182 questionnaires were completed and further analyzed. Physicians have highlighted the need for a low re-fracture rate and to improve life expectancy for more than 1 year (50% for responders of the orthopedics-traumatology questionnaire and 80% for the responders interested in both indications), as well as quality of life (12.5% and 31%, respectively), but with no significant differences in the oncologic indication. Most of the experts were willing to use or prescribe implantable devices for prevention (63% in orthopedics-traumatology and 93% in oncology), although limited clinical experience (54 and 58%) and surgical risk (around 30% in each indication) were considered as limits. Conclusions: Prevention of hip fracture remains a concern for physicians. More clinical experience with implantable devices, in particular in cancer patients, is needed, but implemented in a strategy to maximize patient recovery while reducing costs.
Highlights
Hip fractures, due to bone fragility, either caused by osteoporosis or the presence of metastases in the bone, can be devastating for elderly and cancer patients [1,2,3,4,5,6]
Prevention of hip fracture remains a concern for physicians
A global call for action has been initiated by the Fragility Fracture Network (FFN), involving several leading medical organizations worldwide, to improve the care of patients suffering from hip fracture [9]
Summary
Due to bone fragility, either caused by osteoporosis or the presence of metastases in the bone, can be devastating for elderly and cancer patients [1,2,3,4,5,6] It reduces quality of life and life expectancy. A global call for action has been initiated by the Fragility Fracture Network (FFN), involving several leading medical organizations worldwide, to improve the care of patients suffering from hip fracture [9]. Completed questionnaires were analyzed and compared according to two indications: orthopedics-traumatology and oncology Factors associated with these responses were assessed using univariable analyses, based on chi-square tests or an exact Fisher test, as appropriate
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
